A recent study suggests that liraglutide, a drug similar to Ozempic, may reduce migraine frequency in obese individuals with chronic migraines. Participants experienced nearly a 50% reduction in ...

People with unresponsive chronic migraine and obesity experienced substantial relief after they started taking a GLP-1 drug, ...

A novel medication out of Sweden has shown some of the same promise in melting belly fat — without making your stomach churn.

Already a household name in diabetes and weight management, Ozempic (semaglutide) may soon find another surprising role — as ...

Having to take Ozempic or other weight loss drugs can be a real pain in the ass, with users often having to jab themselves ...

A new oral drug mimics exercise, burns fat, lowers blood sugar, and preserves muscle mass, potentially outperforming Ozempic ...

Novo Nordisk dropped a pile of scientific data on three new experimental weight-loss drugs, including an oral one, showing ...

Almonds, pistachios, and walnuts may help boost GLP-1 thanks to their fiber, protein, and healthy fats. These nutrients work ...

Novo Nordisk AS and a group of insurers will pay $32 million to end litigation over its $1.8 billion acquisition of ...

Novo Nordisk’s campaign, which aims to speak ‘without filters’ by declaring obesity a disease, has been strongly criticized ...

Diabetics are more likely to develop Alzheimer’s than the general public. Could a popular diabetes and weight-loss drug also stave off dementia?

Nearly 90 percent of Dutch citizens believe that obesity medication should be covered by the basic health insurance package, ...